Human Pathology
Volume 37, Issue 3 , Pages 264-271 , March 2006

Correlation and significance of histopathological and clinical features in breast cancer with skin involvement (T4b)

  • Uwe Güth, MD

      Affiliations

    • Department of Gynecology and Obstetrics, University Hospital Basel (UHB), CH-4031 Basel, Switzerland
  • ,
  • Edward Wight, MD

      Affiliations

    • Department of Gynecology and Obstetrics, University Hospital Basel (UHB), CH-4031 Basel, Switzerland
  • ,
  • Andreas Schötzau, MS

      Affiliations

    • JPS Institute for Biomathematics, CH-4052 Basel, Switzerland
  • ,
  • Igor Langer, MD

      Affiliations

    • Department of Surgery, UHB, CH-4031 Basel, Switzerland
  • ,
  • Holger Dieterich, MD

      Affiliations

    • Women's Hospital and Breast Center Rheinfelden, D-79618 Rheinfelden, Germany
  • ,
  • Christoph Rochlitz, MD

      Affiliations

    • Department of Medical Oncology, UHB, CH-4031 Basel, Switzerland
  • ,
  • Linda Herberich, MD

      Affiliations

    • Department of Gynecology and Obstetrics, University Hospital Basel (UHB), CH-4031 Basel, Switzerland
  • ,
  • Wolfgang Holzgreve, MD

      Affiliations

    • Department of Gynecology and Obstetrics, University Hospital Basel (UHB), CH-4031 Basel, Switzerland
  • ,
  • Michael J. Mihatsch, MD

      Affiliations

    • Institute of Pathology, University of Basel, CH-4031 Basel, Switzerland
  • ,
  • Gad Singer, MD

      Affiliations

    • Institute of Pathology, University of Basel, CH-4031 Basel, Switzerland
    • Corresponding Author InformationCorresponding author.

Received 30 June 2005 ,Revised 16 November 2005 ,Accepted 16 November 2005.

References 

  1. In:  Greene F,  Page D,  Fleming I, et al. editor. AJCC cancer staging manual. 6th ed.. New York: Springer; 2002;
  2. In:  Sobin L,  Wittekind C editor. TNM Classification of malignant tumors. 6th ed.. New York: Wiley; 2002;
  3. In:  Wittekind C,  Greene FL,  Henson DE, et al. editor. TNM Supplement. A commentary on uniform use. 3rd ed.. New York: Wiley-Liss; 2004;p. 53–56
  4. Guth U, Moch H, Herberich L, et al. Noninflammatory breast carcinoma with skin involvement. Cancer. 2004;100:470–478
  5. Shen J, Valero V, Buchholz TA, et al. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol. 2004;11:854–860
  6. Zucali R, Kenda R. Small size T4 breast cancer. Natural history and prognosis. Tumori. 1981;67:225–230
  7. Wieland AW, Louwman MW, Voogd AC, et al. Determinants of prognosis in breast cancer patients with tumor involvement of the skin (pT4b). Breast J. 2004;10:123–128
  8. Poole GV, Thigpen JT, Vance RB, et al. Management of women who present with T4 breast cancer. Am Surg. 2004;70:662–666[discussion 666-7]
  9. Price A, Kerr GR, Rodger A. Primary radiotherapy for T4 breast cancer. Clin Oncol (R Coll Radiol). 1992;4:217–221
  10. Touboul E, Lefranc JP, Blondon J, et al. Multidisciplinary treatment approach to locally advanced non-inflammatory breast cancer using chemotherapy and radiotherapy with or without surgery. Radiother Oncol. 1992;25:167–175
  11. Touboul E, Lefranc JP, Blondon J, et al. Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer. Radiother Oncol. 1997;42:219–229
  12. Valagussa P, Zambetti M, Bignami P, et al. T3b-T4 breast cancer: factors affecting results in combined modality treatments. Clin Exp Metastasis. 1983;1:191–202
  13. Valagussa P, Zambetti M, Bonadonna G, et al. Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy. Breast Cancer Res Treat. 1990;15:137–147
  14. Yildirim E, Semerci E, Berberoglu U. The analysis of prognostic factors in stage III-B non-inflammatory breast cancer. Eur J Surg Oncol. 2000;26:34–38
  15. Rubens RD, Armitage P, Winter PJ, et al. Prognosis in inoperable stage III carcinoma of the breast. Eur J Cancer. 1977;13:805–811
  16. Rao DV, Bedwinek J, Perez C, et al. Prognostic indicators in stage III and localized stage IV breast cancer. Cancer. 1982;50:2037–2043
  17. Sutherland CM, Mather FJ. Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment). Cancer. 1985;55:1389–1397
  18. El-Tamer M, Hussain S, Weedon J, et al. Prognoses of T4 breast cancer subsets. Ann Surg Oncol. 2002;9:340–345
  19. Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer. 1988;62:2507–2516
  20. Sloane J. Infiltrating carcinoma—pathological types. In:  Sloane J editors. Biopsy pathology of the breast. 2nd ed.. London: Arnold; 2001;p. 170–214
  21. Speyer J, Muggia F. Management of locally advanced breast cancer. In:  Roses D editors. Breast cancer. 1st ed.. Philadelphia: Churchill Livingstone; 1999;p. 493–502
  22. Rosen P. Unusual clinical presentations of carcinoma. In:  Rosen P editors. Rosen's breast pathology. 2nd ed.. Philadelphia: Lippincott Williams & Wilkins; 2001;p. 653–687
  23. Ikomi F, Schmid-Schonbein GW. Lymph transport in the skin. Clin Dermatol. 1995;13:419–427
  24. Skobe M, Detmar M. Structure, function, and molecular control of the skin lymphatic system. J Investig Dermatol Symp Proc. 2000;5:14–19
  25. Duenne AA, Werner JA. Functional anatomy of lymphatic vessels under the aspect of tumor invasion. Recent Results Cancer Res. 2000;157:82–89

PII: S0046-8177(05)00652-0

doi: 10.1016/j.humpath.2005.11.009

Human Pathology
Volume 37, Issue 3 , Pages 264-271 , March 2006